Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.75 USD | +2.52% | +7.33% | -28.58% |
May. 31 | Piper Sandler Starts Apellis Pharmaceuticals With Neutral Rating, $46 Price Target | MT |
May. 24 | Apellis Pharmaceuticals, Sobi Say Pegcetacoplan Reduces Post-Transplant Kidney Diseases | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.58% | 5.06B | |
-0.75% | 92.26B | |
-2.63% | 38.11B | |
-12.76% | 32.9B | |
+66.54% | 26.51B | |
-13.02% | 15.75B | |
-5.27% | 13.36B | |
-10.50% | 11.65B | |
-49.11% | 10.12B | |
+187.82% | 9.78B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Apellis Pharmaceuticals : Health Care Stocks Ail During Friday Trading